Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Taysha Gene Therapies Inc (NASDAQ: TSHA) closed the day trading at $2.07 down -8.00% from the previous closing price of $2.25. In other words, the price has decreased by -$8.00 from its previous closing price. On the day, 4.53 million shares were traded. TSHA stock price reached its highest trading level at $2.265 during the session, while it also had its lowest trading level at $2.04.
Ratios:
For a better understanding of TSHA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.51 and its Current Ratio is at 5.51. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSHA now has a Market Capitalization of 424232000 and an Enterprise Value of 457429760. For the stock, the TTM Price-to-Sale (P/S) ratio is 39.38 while its Price-to-Book (P/B) ratio in mrq is 4.78. Its current Enterprise Value per Revenue stands at 46.135 whereas that against EBITDA is -5.637.
Stock Price History:
Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $1.19. The 50-Day Moving Average of the stock is -2.68%, while the 200-Day Moving Average is calculated to be -15.53%.
Shares Statistics:
Over the past 3-months, TSHA traded about 4.22M shares per day on average, while over the past 10 days, TSHA traded about 4664810 shares per day. A total of 204.94M shares are outstanding, with a floating share count of 153.61M. Insiders hold about 25.05% of the company’s shares, while institutions hold 69.54% stake in the company. Shares short for TSHA as of 1732838400 were 15670007 with a Short Ratio of 3.71, compared to 1730332800 on 17637427. Therefore, it implies a Short% of Shares Outstanding of 15670007 and a Short% of Float of 10.09.
